Evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse model

BACKGROUND & OBJECTIVES: Current therapy for leishmaniasis is limited and unsatisfactory. Amphotericin B, a second-line treatment is gradually replacing antimonials, the first-line treatment and is used as the preferred treatments in some regions. Though, presently it is the only drug with highe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Jyotsna, Dey, Ayan, Singh, Niti, Somvanshi, Ramesh, Singh, Sarman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724259/
https://www.ncbi.nlm.nih.gov/pubmed/23703346

Ejemplares similares

Ejemplares similares